These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19434630)

  • 21. Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
    Chou S; Marousek GI
    J Virol; 2008 Jan; 82(1):246-53. PubMed ID: 17942550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.
    Chou S
    Antimicrob Agents Chemother; 2009 Jan; 53(1):81-5. PubMed ID: 18981262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conserved domains and structure prediction of human cytomegalovirus UL27 protein.
    Hantz S; Couvreux A; Champier G; Trapes L; Cotin S; Denis F; Bouaziz S; Alain S
    Antivir Ther; 2009; 14(5):663-72. PubMed ID: 19704169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation.
    Wolf DG; Courcelle CT; Prichard MN; Mocarski ES
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1895-900. PubMed ID: 11172047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.
    Komazin G; Ptak RG; Emmer BT; Townsend LB; Drach JC
    J Virol; 2003 Nov; 77(21):11499-506. PubMed ID: 14557635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir.
    Chou S; Marousek GI; Senters AE; Davis MG; Biron KK
    J Virol; 2004 Jul; 78(13):7124-30. PubMed ID: 15194788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maribavir: a novel antiviral agent with activity against cytomegalovirus.
    Trofe J; Pote L; Wade E; Blumberg E; Bloom RD
    Ann Pharmacother; 2008 Oct; 42(10):1447-57. PubMed ID: 18698013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection.
    Chou S; Wu J; Song K; Bo T
    Antiviral Res; 2019 Dec; 172():104616. PubMed ID: 31568799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.
    Prichard MN; Britt WJ; Daily SL; Hartline CB; Kern ER
    J Virol; 2005 Dec; 79(24):15494-502. PubMed ID: 16306620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication.
    Gershburg E; Hong K; Pagano JS
    Antimicrob Agents Chemother; 2004 May; 48(5):1900-3. PubMed ID: 15105156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.
    Gill RB; James SH; Prichard MN
    J Gen Virol; 2012 Aug; 93(Pt 8):1743-1755. PubMed ID: 22552942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
    Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.
    Prichard MN; Sztul E; Daily SL; Perry AL; Frederick SL; Gill RB; Hartline CB; Streblow DN; Varnum SM; Smith RD; Kern ER
    J Virol; 2008 May; 82(10):5054-67. PubMed ID: 18321963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase.
    Kamil JP; Hume AJ; Jurak I; Münger K; Kalejta RF; Coen DM
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16823-8. PubMed ID: 19805380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.
    Iwahori S; Umaña AC; VanDeusen HR; Kalejta RF
    J Biol Chem; 2017 Apr; 292(16):6583-6599. PubMed ID: 28289097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.
    Silva LA; Strang BL; Lin EW; Kamil JP; Coen DM
    Virology; 2011 Sep; 417(2):268-80. PubMed ID: 21784501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.
    Hakki M; Drummond C; Houser B; Marousek G; Chou S
    Antiviral Res; 2011 Nov; 92(2):313-8. PubMed ID: 21906628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells.
    Sharma M; Kamil JP; Coughlin M; Reim NI; Coen DM
    J Virol; 2014 Jan; 88(1):249-62. PubMed ID: 24155370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.
    Bigley TM; Reitsma JM; Terhune SS
    J Virol; 2015 Oct; 89(20):10230-46. PubMed ID: 26223645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase.
    Krosky PM; Baek MC; Jahng WJ; Barrera I; Harvey RJ; Biron KK; Coen DM; Sethna PB
    J Virol; 2003 Jul; 77(14):7720-7. PubMed ID: 12829811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.